The Ninth Circuit Court of Appeals has reversed a lower court's ruling that favored Align Technology, Inc. in an antitrust case. This decision allows two groups of plaintiffs to continue their claims against Align, the maker of the popular Invisalign dental aligners and iTero intraoral scanners. The court's ruling is significant as it addresses allegations of anticompetitive behavior that could impact the dental industry and consumers alike.
The case, known as Snow v. Align Technology, Inc., was filed under docket number 24-1783. The plaintiffs, which include dental practices and individual consumers, allege that Align engaged in an anticompetitive scheme to monopolize the aligner and scanner markets. They claim that Align's actions harmed competition and limited consumer choices.
Background
The plaintiffs in this case are two groups: one led by Simon & Simon, PC, representing dental practices, and another led by Misty Snow, representing individual consumers. Both groups filed class action lawsuits against Align Technology, alleging violations of Section 2 of the Sherman Act, which prohibits monopolistic practices.
Simon & Simon filed their lawsuit in 2020, claiming that Align's termination of a digital interoperability agreement with 3Shape, a rival scanner manufacturer, was part of an anticompetitive scheme. This agreement allowed for the seamless integration of Align's products with competing scanners. Snow's group followed in 2021, alleging similar claims and seeking damages under both federal and state antitrust laws.
The lower court initially denied Align's motion to dismiss the case, allowing it to proceed. However, when Align later sought summary judgment, the district court ruled in favor of Align, stating that the company had legitimate business reasons for its actions, despite acknowledging that Align may have been motivated by a desire to harm its competitors.
The Ruling
The Ninth Circuit Court of Appeals, in its recent ruling, reversed the district court's summary judgment in favor of Align Technology. The court found that the plaintiffs had established a prima facie case of anticompetitive conduct. The judges noted that Align's termination of the interoperability agreement with 3Shape met the criteria outlined in the Aspen Skiing case, which is a key precedent in antitrust law.
The court stated, "At step one, plaintiffs established a prima facie case. The market at issue was the aligner market. As to this market, all three Aspen Skiing factors were satisfied."
The court explained that the burden of proof then shifted to Align to provide a legitimate business justification for its actions. Align argued that terminating the agreement was necessary to strengthen its position in ongoing patent litigation against 3Shape. However, the court found that the plaintiffs presented sufficient evidence to create genuine disputes of material fact regarding whether Align's justification was genuinely procompetitive or merely a pretext.
The court concluded, "Plaintiffs have presented sufficient evidence to create genuine disputes of material fact over whether Align’s proffered justification was legitimately procompetitive and whether it was pretextual."
Impact
This ruling is significant as it allows the plaintiffs' antitrust claims against Align to proceed to trial. The decision emphasizes the importance of scrutinizing the motives behind business decisions, especially when they involve potential monopolistic practices. The outcome of this case could have broader implications for the dental industry and how companies interact with competitors.
The court's ruling also clarifies the burden-shifting framework used in antitrust cases, particularly those involving refusals to deal. This framework requires that plaintiffs first establish a prima facie case of anticompetitive conduct, after which the burden shifts to the defendant to justify its actions. If the defendant provides a justification, the burden shifts back to the plaintiff to rebut that justification.
What's Next
The case will now return to the lower court for further proceedings. Align Technology may choose to appeal the Ninth Circuit's decision, but details on any potential appeal were not available in the court filing. The outcome of this case could set important precedents for future antitrust litigation, particularly in the healthcare and technology sectors.